A Clinical trial to assess the effect of Natural Killer Cell transplantation in treatment of patients with Acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL)

Stem Cell And Regenerative Medicine Institute0 个研究点目标入组 10 人开始时间: 待定最近更新: 2018年2月22日

试验速览

暂无简介。

•1-Age range of 18- 25 years for ALL patients; 2-Age range over 50 years for patients with CLL; 3- Those who have a proper cell donors with incongruent KIR (Haploidentical KIR-L mismatched donor); 4- Patients with adequate organ function; 5-Access to the patient for the continuation of treatment and follow-up (preferably from Azeri-speaking patients for easier access and removal of the Zentique variable);
•Exclusion criteria : 1-Patients with active and uncontrolled infections; 2-Abnormal kidney, lung and liver function, measured by serum creatinine (serum creatinine> 2 mg / dl), saturated oxygen O2 = 96%) (Sat and liver enzymes (ALT / AST> 2.5 x N); 3-Patients with Down syndrome; 4- Patients with acute promyelocytic leukemia

发起方

Stem Cell And Regenerative Medicine Institute